Leerink Partners Begins Coverage on Medpace (NASDAQ:MEDP)

Investment analysts at Leerink Partners assumed coverage on shares of Medpace (NASDAQ:MEDP – Get Free Report) in a report issued on Monday, Marketbeat Ratings reports. The firm set a “market perform” rating and a $330.00 price target on the stock. Leerink Partners’ price target indicates a potential upside of 1.69% from the stock’s previous close. […]

Leave a Reply

Your email address will not be published.

Previous post Dear Abby: Miffed when married neighbor ends affair
Next post Oppenheimer Initiates Coverage on Quince Therapeutics (NASDAQ:QNCX)